Hospital Universitario De La Princesa — Clinical Trial Site

315 Registered trials

104 Currently recruiting

Organisation

Hospital Universitario De La Princesa

Location

Madrid, Spain

Identifier

ORG-100028549

Address

Calle De Diego De Leon 62, 28006, Spain

Departments

#2320:servicio de neurología
#5408 :neurologia
#7002:Dermatología
#724005: Neurologia
#8004:Cirugía cardíaca
#ES10007:Aparato Digestivo
0656: Servicio de Neurologia
1104 : Dermatología
1325: Hematología y Oncología
2749; Dermatología
2804:Dermatología
3121: medicina interna
3206: Hematologia
6509: Dermatología
7217: Neurology
9762; Dermatología
Allergology
Allergy
Anestesia
Anestesiología y Reanimación
Anesthesiology
Aparato Digestivo
Cardiac surgery
Cardiología
Cardiology
Clinical Pharmacology
Clinical Pharmacology Department
Clinical Pharmacology Service
Departamento de Neurología
Departamento de Oncología
Department of Clinical Trials
Dermatologia
Dermatologist
Dermatology
Digestive
Digestive department
Digestive service
Digestive system
Digestivo
Endocrinología y metabolismo
Endocrinology
Enfermedades Infecciosas
ES10002: Aparato Digestivo
Gastroenterologia
Gastroenterologist
Gastroenterology
Gastroenterology and Hepatology Department
General Surgery
Haematology
Hematologia
Hematology
Hematology department
Hematology Service
Hospital La Princesa
Infectious department
Infectious Disease
Infectious Disease Department
Infectious Diseases
Intensive care medicine
Intensive Medicine
Intensive Medicine Department
internal Medicine
Internal Medicine Service / Infectious Diseases Unit
Internal medicine-Infectious Diseases
IP Hospital Universitario de La Princesa
Jefa de Servicio de Reumatologia
Manzanares
Maxilofacial
Medical Neurosurgery
Medical Oncology
Medicina Interna
Medicina Interna-Infecciosas
N/A
NA
Nefrology
Nephrology
NEUMOLOGÍA
Neurología
Neurology
Neurology Department
Neurology Service
not applicable
oncologia
Oncology
Oncology department
Oncology service
Pharmacology
Physical Medicine and Rehabilitation
Pneumology
Pneumology Department
Pneumonology
Pulmonogy
Pulmonología
Pulmonology
Radiation Oncology
Respiratory
Respiratory medicine
Reumatología
Rheumatology
Servicio de digestivo
Servicio de Alergia
Servicio de Aparato Digestivo
Servicio de Enfermedades Infecciosas y Medicina Interna.
Servicio de Farmacología Clínica
Servicio de Gastroenterología
Servicio de Hematologia
Servicio de Infecciosas
Servicio de Medicina Interna
Servicio de Neumología
Servicio de Neurologia
Servicio de Oncología
Servicio de Oncologia Medica
Servicio Neumología
Surgery
UCG Enfermedades Infecciosas, Microbiología y Medicina preventiva
Unidad de Cirugía Cardiovascular
Unidad de Enfermedad Inflamatoria Intestinal
Unidad de Ensayos Clínicos Fase 1
Unidad de Ensayos Clínicos Fase I
Unidad del Dolor
Urology
Urology Deparment

Clinical trials at this site (315)

Search interface

Pragmatic clinical trial to assess the utility of SLCO1B1, ABCG2, and CYP2C9 preemtive genotyping and pharmacogenetics training on the incid… Recruiting

2023-506814-31-01 Cardiovascular risk which needs primary or secundary pr 6 2024-06-25
MorningLyte: Evaluation of the benefits of the combination of mosunetuzumab plus lenalidomide versus a treatment with anti-CD20 monoclonal a… Recruiting

2023-505436-35-00 Untreated FLIPI 2-5 Follicular Lymphoma 5 2024-06-03
A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants with Chronic Mye… Recruiting

2023-507677-18-00 Chronic Myeloid Leukemia 9 2024-05-17
CHOP PLUS MOSUNETUZUMAB AS FIRST LINE IN PATIENTS WITH RICHTER´S SYNDROME: A PHASE II STUDY OF THE SPANISH GROUP OF CLL (GELLC-9-RICHTER) Recruiting

2023-505621-13-00 Richter´syndrome 4 2024-05-14
A clinical study to compare MK-2870 with pembrolizumab to pembrolizumab alone in people with lung cancer (MK-2870-007) Recruiting

2023-503376-24-00 Metastatic non-small cell lung cancer (NSCLC) 5 2024-03-20
A Randomized, Multicenter, Placebo-controlled, Phase 3 study to Evaluate the Efficacy and Safety of HER2/neu Peptide GLSI-100 (GP2 + GM-CSF)… Recruiting

2023-504323-25-01 breast cancer 5 2024-03-19
A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease (PASADENA) Recruiting

2023-504472-24-00 Early Idiopathic Parkinson’s disease (PD) 4 2024-03-19
Study Comparing the Efficacy and Safety of the Combination of Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib… Recruiting

2023-503708-10-00 Locally advanced or metastatic breast cancer 5 2024-02-20
Phase III, double-blind, randomised, placebo- and active treatment-controlled clinical trial to evaluate the analgesic efficacy and safety o… Recruiting

2023-505687-11-00 Acute pain 5 2024-02-06
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare Recruiting

2024-518844-20-00 Treatment of Acute Gout Flare 10 2023-10-03
Multicenter, randomized, double-blind, and placebo-controlled clinical trial to assess the efficacy and safety of donepezil versus placebo i… Recruiting

2024-510959-35-00 Parkinson's disease 4 2023-09-07
An adaptive, Phase 2, double-blind, randomized, placebo-controlled, multicenter study to evaluate the safety, tolerability, immunogenicity, … Recruiting

2022-500292-31-00 Early stages of idiopathic Parkinson's Disease 4 2023-05-12
MagnetisMM-6: A Phase 3 Study of Elranatamab (PF-06863135) + Daratumumab + Lenalidomide Versus Daratumumab + Bortezomib + Lenalidomide + Dex… Recruiting

2024-514139-50-00 Multiple myeloma 5 2022-11-14
A phase 1b/2, multicenter, adaptive, double-blind, randomized, placebo-controlled study to assess the safety, tolerability, immunogenicity, … Recruiting

2022-500069-29-00 Alzheimer's disease 9 2022-11-02
Randomized clinical trial to evaluate the utility of CYP2D6 genotyping to improve the efficacy and safety of tramadol in the treatment of ac… Recruiting

2022-500377-13-01 Pharmakogenetics 6 2022-10-05
Asciminib Roll-over Study Recruiting

2023-507557-16-00 chronic myelogenous leukemia (CML) or Philadelphia Chro 5 2022-08-31
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple M… Recruiting

2023-506247-42-00 Relapsed/Refractory Multiple Myeloma 3 2022-08-17
Effect of Tofacitinib on coagulation and platelet function, and its role in thromboembolic events Recruiting

2024-518434-83-01 ulcerative colitis 6 2022-06-01
FI-3, Fidelia Recruiting

2024-518243-38-00 Fecal incontinence in female and male patients 5 2022-04-20
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants Wi… Recruiting

2023-504599-10-00 Chronic lymphocytic leukemia recurrent 4 2022-03-29
Single antiplatelet treatment with Ticagrelor or Aspirin after Transcatheter Aortic Valve Implantation: multicenter randomized clinical tria… Recruiting

2023-509290-22-00 Severe Symptomatic Aortic Stenosis 6 2022-01-21
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
A Phase 1/2a, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of HDP-101 in Patients with Plasma C… Recruiting

2024-515273-10-00 Relapsed or refractory Multiple Myeloma (r/r MM) 7 2021-10-19
A dose escalation followed by dose expansion trial to assess safety and tolerability of CAP-100 in subjects with relapsed/refractory chronic… Recruiting

2024-516341-39-00 Relapsed/refractory chronic lymphocytic leukemia (CLL) 1 2021-08-23